BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37532110)

  • 1. Genetic specification of malignant hyperthermia susceptibility is warranted for assessing fatigue, depression, and exercise intolerance.
    Finsterer J; Scorza FA; Scorza CA
    Braz J Anesthesiol; 2023; 73(6):829-830. PubMed ID: 37532110
    [No Abstract]   [Full Text] [Related]  

  • 2. "Noninvasive" testing for malignant hyperthermia susceptibility.
    Allen PD; López JR
    Anesthesiology; 2002 Nov; 97(5):1045-6. PubMed ID: 12411783
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia.
    Urwyler A; Deufel T; McCarthy T; West S;
    Br J Anaesth; 2001 Feb; 86(2):283-7. PubMed ID: 11573677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current diagnostic methods of malignant hyperthermia: an evaluation.
    Ording H
    Acta Anaesthesiol Belg; 1990; 41(2):103-6. PubMed ID: 2371801
    [No Abstract]   [Full Text] [Related]  

  • 5. [Detection of peranesthetic malignant hyperthermia by muscle contracture tests and NMR spectroscopy].
    Kozak-Reiss G; Gascard JP; Redouane-Bénichou K
    Ann Fr Anesth Reanim; 1986; 5(6):584-9. PubMed ID: 3826791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modern diagnostic approaches to malignant hyperthermia susceptibility].
    Kazantseva AA; Lebedinskiĭ KM
    Anesteziol Reanimatol; 2014; 59(4):64-8. PubMed ID: 25549489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurological aspects of malignant hyperthermia. Clinics, physiopathology, genetics].
    Serratrice G; Kozak-Ribbens G; Cozzone PJ
    Rev Neurol (Paris); 1997 Jun; 153(5):304-13. PubMed ID: 9296164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility.
    Hopkins PM; Rüffert H; Snoeck MM; Girard T; Glahn KP; Ellis FR; Müller CR; Urwyler A;
    Br J Anaesth; 2015 Oct; 115(4):531-9. PubMed ID: 26188342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant hyperthermia in China.
    Xu ZH; Luo AL; Guo XY; Ren HZ; Wang YL; Zhang X; Huang YG; Ye TH
    Anesth Analg; 2006 Oct; 103(4):983-5. PubMed ID: 17000816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatigue, depression, and physical activity in patients with malignant hyperthermia: a cross-sectional observational study.
    Andrade PMV; Valim LÍM; Santos JMD; Castro I; Amaral JLGD; Silva HCAD
    Braz J Anesthesiol; 2023; 73(2):132-137. PubMed ID: 34626754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant hyperthermia].
    Glahn KP
    Ugeskr Laeger; 2003 Apr; 165(17):1763-8. PubMed ID: 12768904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant hyperthermia.
    Rosenberg H
    Hosp Pract (Off Ed); 1985 Mar; 20(3):139, 144-5, 148 passim. PubMed ID: 3932397
    [No Abstract]   [Full Text] [Related]  

  • 13. Is the "K-type" caffeine-halothane responder susceptible to malignant hyperthermia?
    Ellis FR; Halsall PJ; Hopkins PM
    Br J Anaesth; 1992 Nov; 69(5):468-70. PubMed ID: 1467078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic testing for malignant hyperthermia in North America.
    Nelson TE; Rosenberg H; Muldoon SM
    Anesthesiology; 2004 Feb; 100(2):212-4. PubMed ID: 14739790
    [No Abstract]   [Full Text] [Related]  

  • 15. [Malignant hyperthermia--progress in diagnosis?].
    Roewer N; Hartung E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Aug; 31(6):331-3. PubMed ID: 8962926
    [No Abstract]   [Full Text] [Related]  

  • 16. Malignant hyperthermia susceptibility revealed by increased serum creatine kinase concentrations during statin treatment.
    Krivosic-Horber R; Dépret T; Wagner JM; Maurage CA
    Eur J Anaesthesiol; 2004 Jul; 21(7):572-4. PubMed ID: 15318472
    [No Abstract]   [Full Text] [Related]  

  • 17. Malignant hyperthermia and central core disease: disorders of Ca2+ release channels.
    Loke J; MacLennan DH
    Am J Med; 1998 May; 104(5):470-86. PubMed ID: 9626031
    [No Abstract]   [Full Text] [Related]  

  • 18. Spontaneous occurrence of the disposition to malignant hyperthermia.
    Rueffert H; Olthoff D; Deutrich C
    Anesthesiology; 2004 Mar; 100(3):731-3. PubMed ID: 15108991
    [No Abstract]   [Full Text] [Related]  

  • 19. Genomic Screening for Malignant Hyperthermia Susceptibility.
    Biesecker LG; Dirksen RT; Girard T; Hopkins PM; Riazi S; Rosenberg H; Stowell K; Weber J
    Anesthesiology; 2020 Dec; 133(6):1277-1282. PubMed ID: 32898259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant hyperthermia--a hereditary and potentially life-threatening condition].
    Haugen T; Toft M; Müller CR; Aasly J
    Tidsskr Nor Laegeforen; 2005 Oct; 125(20):2792-4. PubMed ID: 16244682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.